| Product Code: ETC9966887 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Genome Engineering Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Genome Engineering Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Genome Engineering Market - Industry Life Cycle |
3.4 United States (US) Genome Engineering Market - Porter's Five Forces |
3.5 United States (US) Genome Engineering Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 United States (US) Genome Engineering Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 United States (US) Genome Engineering Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 United States (US) Genome Engineering Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and gene therapy |
4.2.2 Technological advancements in genome editing tools and techniques |
4.2.3 Rising investments in genomics research and development |
4.3 Market Restraints |
4.3.1 Ethical and regulatory concerns surrounding genome editing |
4.3.2 High costs associated with genome engineering technologies |
4.3.3 Limited awareness and understanding of genome engineering among healthcare professionals and the general population |
5 United States (US) Genome Engineering Market Trends |
6 United States (US) Genome Engineering Market, By Types |
6.1 United States (US) Genome Engineering Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Genome Engineering Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 United States (US) Genome Engineering Market Revenues & Volume, By Clustered regularly interspaced short palindromic repeats (CRISPR), 2021- 2031F |
6.1.4 United States (US) Genome Engineering Market Revenues & Volume, By Transcription activator-like effector nuclease (Talen), 2021- 2031F |
6.1.5 United States (US) Genome Engineering Market Revenues & Volume, By Zinc Finger Nuclease (ZFN), 2021- 2031F |
6.1.6 United States (US) Genome Engineering Market Revenues & Volume, By Other Technologies, 2021- 2031F |
6.2 United States (US) Genome Engineering Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Genome Engineering Market Revenues & Volume, By Cell Line Engineering, 2021- 2031F |
6.2.3 United States (US) Genome Engineering Market Revenues & Volume, By Animal Genome Engineering, 2021- 2031F |
6.2.4 United States (US) Genome Engineering Market Revenues & Volume, By Plant Genome Engineering, 2021- 2031F |
6.2.5 United States (US) Genome Engineering Market Revenues & Volume, By Other Application, 2021- 2031F |
6.3 United States (US) Genome Engineering Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Genome Engineering Market Revenues & Volume, By Pharmaceutical and Biotechnology Companies, 2021- 2031F |
6.3.3 United States (US) Genome Engineering Market Revenues & Volume, By Academics, 2021- 2031F |
6.3.4 United States (US) Genome Engineering Market Revenues & Volume, By Clinical Research Organizations, 2021- 2031F |
7 United States (US) Genome Engineering Market Import-Export Trade Statistics |
7.1 United States (US) Genome Engineering Market Export to Major Countries |
7.2 United States (US) Genome Engineering Market Imports from Major Countries |
8 United States (US) Genome Engineering Market Key Performance Indicators |
8.1 Number of clinical trials utilizing genome engineering technologies |
8.2 Funding and investments in genome engineering companies and research |
8.3 Adoption rate of genome editing tools in healthcare and biotechnology industries |
9 United States (US) Genome Engineering Market - Opportunity Assessment |
9.1 United States (US) Genome Engineering Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 United States (US) Genome Engineering Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 United States (US) Genome Engineering Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 United States (US) Genome Engineering Market - Competitive Landscape |
10.1 United States (US) Genome Engineering Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Genome Engineering Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here